Evidence map›Paper›PMID 41220356›Full record

ArticleThe Canadian journal of urology2025

Single port robotic partial nephrectomy via a retroperitoneal approach.

Joon Yau Leong, Vignesh Prasad, Carlos J Perez Kerkvliet, Andrew A Wagner, Richard E Link, Mihir S Shah

Abstract read
PubMed Publisher
In one paragraph

Article in The Canadian journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joon Yau LeongDepartment of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Vignesh PrasadDrexel University College of Medicine, Philadelphia, PA 19104, USA.
Carlos J Perez KerkvlietDepartment of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Andrew A WagnerDivision of Urology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Richard E LinkScott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
Mihir S ShahDepartment of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the introduction of the Da Vinci Single Port (SP) robotic platform has opened new doors for the treatment of localized renal masses. This technology, particularly when utilized via a regionalized retroperitoneal (RP) approach, offers several distinct advantages that may improve patient recovery. These advantages include easier access to both anterior and posterior renal tumors, avoidance of the peritoneal cavity with complicating adhesions, and simplified supine positioning, potentially reducing the risk of musculoskeletal or nerve injuries. Yet, the learning curve for RP surgery remains steep due to the unfamiliarity of many surgeons with the RP endoscopic perspective and ergonomic challenges of the SP robot. Given this relatively new technology and its growing availability in many institutions, most surgeons remain early in their evolution of performing SP partial nephrectomy (PN). Herein, we discuss our technique for performing SP PN via an RP approach, including port access, anatomic considerations, and operative techniques. Our hope is to familiarize readers with this powerful approach and smooth out early pitfalls during the learning curve.

Indexed as

Kidney NeoplasmsNephrectomyRobotic Surgical ProceduresHumansLearning CurveRetroperitoneal Spacepartial nephrectomyrenal massretroperitonealrobotic surgerysingle port

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.